510(k) K052191
K052191 is an FDA 510(k) premarket notification submitted by Veridex, LLC for the device "MODIFICATION TO CELLSEARCH CIRCULATING TUMOR CELL KIT". The FDA issued a decision of Substantially Equivalent on October 27, 2005. The device falls under product code NQI (System, Immunomagnetic, Circulating Cancer Cell, Enumeration), a Class II device regulated under 21 CFR 866.6020. Veridex, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 27, 2005
- Date Received
- August 11, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Immunomagnetic, Circulating Cancer Cell, Enumeration
- Device Class
- Class II
- Regulation Number
- 866.6020
- Review Panel
- PA
- Submission Type
In vitro diagnostic device to aid in the enumeration of immunomagnetically selected and fluorescently identified circulating tumor cells of epithelial origin in whole blood for prediction of cancer progression and survival.